Introduction
Spectraplakins are multifunctional scaffolding molecules which are highly conserved across the animal kingdom. They comprise mammalian Bpag1/dystonin and ACF7/MACF1, Drosophila Short stop (Shot), and C. elegans Vab-10, all of which code for large proteins of 4-600 kDa weight (Jefferson et al., 2004; Rö per et al., 2002) . Spectraplakins play crucial roles in a broad spectrum of cellular contexts, ranging from roles in highly dynamic cellular processes, such as neuronal growth and differentiation, cell migration (in wound healing) or cell fusion (in tracheal development), to potentially less dynamic roles in cell maintenance (relating to skin blistering and neuronal degeneration; Jefferson et al., 2004; Rö per et al., 2002; Sonnenberg and Liem, 2007) . This impressive breadth of Spectraplakin functions can be molecularly associated with a number of distinct conserved protein domains they harbour (details in Fig. 3 ). For example, the epidermal isoform of BPAG1 acts as a Keratin-to-hemidesmosome linker, mediated by its N-terminal Plakin domain and C-terminal Plakin/Plectin repeats (Aumailley et al., 2006) . In contrast, neuronal degeneration reported for BPAG1 mutant mice (dystonia musculorum; dt) is likely to require actin-microtubule linker functions of long isoforms involving N-terminal Calponin and C-terminal Gas2 domains (Young and Kothary, 2007) . Thus, there is an emerging picture of differential requirements for distinct domains of Spectraplakins, but so far we only seem to scratch the surface of this regulatory potential.
A good model to study domain requirements of Spectraplakins is Drosophila Short stop (Shot). First, Shot is the only Spectraplakin in the fly genome, and it shares a high degree of sequence similarity and the same domain composition with its mammalian homologues ACF7 and BPAG1 (Jefferson et al., 2004; Rö per et al., 2002) . Second, there is a wealth of different cellular contexts in which Shot function has been implicated so far, providing an ideal opportunity to get comparative insights into domain requirements. Third, the genetic amenability of Drosophila facilitates structure-function analyses in vivo. However, in spite of all these advantages, we have so far astonishingly few insights into context-specific domain requirements of Shot: its EF-hand motifs regulate axonal pathfinding (Lee et al., 2007) , its Calponin AND Gas2
Fig. 1 -Features of developing shot mutant motorneurons. (A) Illustration of the principal morphology of developing and mature motorneurons: beige, somatodendritic area; red, axon; curved arrow, soma; black arrow head, primary neurite; white arrow head, dendrites; black arrow, axon; pre, presynaptic terminal; GC and double chevron, growth cone. All other images (except motoraxonal tip in I) show labelled aCC and RP2 neurons in horizontal views of the ventral nerve cord, with symbols indicating the same features as in A; CNS midline is indicated by dashed lines, and is identical with the left fringe of the images in G and H; anterior is up in B-H and left in I. (B-E) Targeted expression of mCD8::GFP surface label reveals normal dendrite morphology, and Baz::GFP restricts normally to the somatodendritic area in shot mutant aCC and RP2 motorneurons at 13 h (developmental time indicated bottom right). (F-I) Shot::GFP enriches in dendrites and growth cones at all stages of their embryonic development. Further markers: Fas2, Fasciclin2; Hom, myc-tagged Homer. Scale bar 8 lm in I and 20 lm in all other images.
domains mediate axon extension (Lee and Kolodziej, 2002b; Sá nchez-Soriano et al., in press ), its Calponin OR Gas2 domains regulate tracheal fusion (Lee and Kolodziej, 2002a) , and its differentially spliced Plakin/Plectin repeats are required to maintain cell junctions in the epidermis (Rö per and Brown, 2003) . Surprisingly, the Plakin-homology domain (Plakin domain) which is the only domain common to all Spectraplakin isoforms (Jefferson et al., 2004; Lee et al., 2000; Rö per et al., 2002; Young and Kothary, 2007) , has so far been neglected in any studies of Shot.
To gain more comprehensive insights into the domain requirements of Shot, we carried out structure-function analyses in three very different, Shot-dependent cellular contexts which we expected to require distinct modes of Shot action. First, developing neurons have to extend axons and dendrites in a stereotypic manner. Axons and dendrites of shot mutant neurons are reduced in size (Lee and Kolodziej, 2002b; Prokop et al., 1998) , and Shot would be expected to coordinate highly dynamic rearrangements of actin and/or microtubules in this context (Dent and Gertler, 2003) . Second, the ability of neurons to signal in a directed manner requires their strict polarity and subdivision into dendritic and axonal compartments. In shot mutant neurons, the compartmentalised localisation of subcellular markers is abolished (Prokop et al., 1998; Reuter et al., 2003) , and Shot would be expected to organise cortical F-actin networks and membrane-associated factors in this context. Third, tendon cells represent specialised epidermal cells which anchor muscle cells basally and adhere to exoskeleton (cuticle) apically. Apico-basal arrays of highly stable actin fibres and microtubules within tendon cells transmit muscle-induced forces to the cuticle. In shot mutant embryos, tendon cells fail to withstand the pulling forces of muscles (Alves-Silva et al., 2008; Prokop et al., 1998; Subramanian et al., 2003) , and Shot would be expected to play a role in the formation and/or maintenance of the highly stable arrays of microtubules in this context. Using these three very different read-outs for structurefunction analyses of Shot in vivo, we could pinpoint a number of differential domain requirements of Shot from which essential statements about Shot function can be deduced. Our data clearly support the view that Spectraplakins function in tissue-specific modes in vivo, and even domains believed to be crucial for their function can be dispensable in specific contexts.
Results

Shot acts as an actin-microtubule linker in motorneuronal dendrites
As described in the Section 1, shot null or severe loss-offunction mutant embryos display reductions in the length of motorneuronal axons and dendrites. Here we used shot 3 or shot sf20 , the strongest known loss-of-function mutant alleles which, in our hands, show comparable phenotypes (from now on referred to as shot mutant). We focussed our analyses on dendrites. In contrast to axonal growth (Dent and Gertler, 2003) , relatively little is known about the cytoskeletal mechanisms underlying dendritic extension and branching (Landgraf and Evers, 2005) and, although Shot is known to be essential for dendrite growth (Gao et al., 1999; Prokop et al., 1998; Reuter et al., 2003) , its role in this context
is not yet understood. We used as a paradigm the dendrites of a subset of motorneurons, the furthest dorsally projecting aCC and RP2 neurons, to which gene expression can be targeted via the eveGal4 driver line (for details about the Gal4/UAS system see Duffy, 2002; Fig. 1) . Targeted expression of the cell surface marker mCD8::GFP clearly showed that dendrites of aCC and RP2 cells in shot null mutant embryos are severely crippled at late embryonic stages (Fig. 2 ) . In contrast, at the onset of dendrite formation (embryonic stage 15 = 12 h; CamposOrtega and Hartenstein, 1997; Sá nchez-Soriano et al., 2005) , we observed no obvious aberrations in shot mutant animals compared to wildtype (Fig. 1) . This observation suggests that Shot function is dispensable for dendrite initiation but plays a role in dendrite extension or branching.
Targeted expression of a GFP-tagged version of full length Shot (Shot::GFP, which represents the Shot-LA isoform (Lee and Kolodziej, 2002b) ) revealed strong localisation to developing dendrites throughout embryogenesis (Fig. 1) . Since comparable data for motoraxons were not available, we analysed Shot::GFP also in this context and found it to accumulate at the axon tip in the area of the growth cone, as indicated by the presence of F-actin rich filopodia (Fig. 1) . Therefore, Shot accumulates at the sites of neurite growth in both axons and dendrites.
When expressing Shot::GFP in motorneurons of shot mutant embryos, their severe dendritic growth phenotypes were clearly rescued (Fig. 2) , thus setting the stage for detailed structure function analyses. To this end, we employed a number of existing transgenic fly lines carrying UAS-constructs coding for domain-specific deletion variants of Shot::GFP (Lee and Kolodziej, 2002b) : DCalp1 (lacks first Calponin domain), Drod (lacks Spectrin repeat rod), DEF (lacks both EFhand motifs), DGas2 (lacks the Gas2 domain; details in Fig. 3 ). When expressing these constructs in wildtype background, no obvious dominant negative effects were observed (Fig. S1 ). Then we targeted these constructs to motorneurons of shot mutant embryos, to assess their capabilities to rescue dendritic morphology. These experiments revealed a strong requirement for the F-actin-binding Calponin and microtubule-associating Gas2 domains, both of which failed to achieve rescue ( Fig. 2C 0 and F 0 ), suggesting Shot to act as an actin-microtubule linker in this context. One explanation for the inability of domain-deficient Shot proteins to achieve proper rescue of shot mutant phenotypes could be their inability to localise properly in dendrites. However, the observed failure of DGas2 and DCalp1 to rescue dendrite morphology is not simply due to their absence from dendrites. Thus, DCalp1 shows a completely normal localisation pattern (Fig. 2C) , and DGas2 can clearly be found homogeneously distributed in dendrites as well as axons (Fig. 2F) . Also DEF, which accumulates in a punctate pattern in dendrites, fails to rescue dendritic growth (Fig. 2E ). Only Drod can rescue normally extending dendrites (although they appear less branched), in spite of the fact that it displays strong homogeneous mislocalisation along microtubules throughout the somatodendritic compartment (details in Fig. 2D ). Our findings suggest that the extension of dendrites depends on Calponin, EF and Gas2 domains of Shot, i.e. the same domains which are required for axonal growth (Lee and Kolodziej, 2002b) . Shot seems to function as an essential elongator in axons and dendrites, in spite of the fact that both neurite types display very distinct morphologies. The results with Drod suggest that Shot also seems to play a role in dendrite branching.
Shot acts as an actin-microtubule linker in Fasciclin2 localisation
In the absence of Shot, motorneurons display a severe mislocalisation of the neural cell adhesion molecule Fasciclin2 in the somatodendritic compartment (Prokop et al., 1998) . This phenotype could reflect loss of neuronal polarity, since polarity defects have been suggested to occur in shot mutant interneurons (Reuter et al., 2003) . To test for polarity defects in aCC and RP2 neurons, we analysed localisation of the polarity marker Baz::GFP, which has been shown to accumulate in the early dendritic compartment of wildtype motorneurons (Sá nchez-Soriano et al., 2005) . However, the Baz::GFP localisation pattern is conserved in shot mutant motorneurons ( Fig. 1E ), suggesting that Shot is not required to set up the dendritic compartment, consistent with the finding that early dendrite outgrowth is unaffected in shot mutant motorneurons (Fig. 1C) .
In order to determine domain requirements of Shot in Fasciclin2 localisation, we expressed the deletion constructs of Shot with the pan-neuronal driver elav-Gal4 in shot mutant embryos. Of the four deletion constructs tested, Drod DCalp1 localises normal; DEF localises to dendrites in a more fragmented punctate fashion; Drod is clearly more strongly localised in dendrites than in axons, but it displays an abnormally even distribution along microtubules throughout the somatodendritic compartment; round aggregates of GFP in somata are typical of Drod which we could not map to any subcellular structure; DGas2 fails to enrich in the somatodendritic compartment and is evenly distributed in all neurites. Rescue of morphology (right columns): DCalp1, DEF and DGas2 fail to rescue and show typically reduced complexity of shot mutant dendrites (A 0 ), whereas Drod-expressing dendrites expand normally but appear less arborised. Scale bar 10 lm in B-F, 6 lm in A, A 0 -F, 0 and 4.5 lm in all insets.
achieved a full rescue, whereas DCalp1, DEF and DGas2 all failed to rescue the shot null mutant phenotype (Fig. 4) . So, compartmentalisation of Fasciclin2 appears to require actinto-microtubule linker activity of Shot, as well as additional functions provided through EF-hand domains. EF-hand domains were shown recently to interact with the putative translational regulator Krasavietz/eIF5 (Kra; Lee et al., 2007) . However, late stage 17 kra mutant embryos did not display any mislocalisation of FasciclinII in nerve roots, suggesting that Shot does not interact with Kra in this context (data not shown).
The F-actin binding Calponin domain is dispensable in tendon cells
In order to extend the structure-function analysis of Shot to the very different cellular context of tendon cells, we used the previously published Gal4-driver line sr-Gal4 which targets expression to this highly specialised epidermal cell type. Using either flat dissection or a newly developed pressure injection strategy (Section 2), it is possible to analyse tendon cells in late stage 17 shot mutant embryos (Figs. 5 and S2). Such shot mutant tendon cells are dramatically elongated, held together only through their persisting apico-basal F-actin arrays (Alves-Silva et al., 2008) . Targeted expression of Shot::GFP completely rescued the shot mutant tendon cell phenotype, thus setting the stage for structure-function analyses (details in Figs. 5 and S2).
In these analyses, the expression of DGas2 failed to improve the shot mutant phenotype, whereas expression of DCalp1 achieved an almost complete rescue. These findings suggest that binding of Shot to microtubules, but not to F-ac- Fig. 3 -Schematic presentation of Shot constructs and antibodies. Shot::GFP is the template used for all other constructs. It harbours two Calponin domains (Calp1+2), a Plakin-like domain, a Spectrin repeat rod, two EF-hand motifs, a Gas2 domain and a C-terminal GFP tag. Numbers indicate domain borders and refer to AAM68561 in NCBI. Lines on top indicate the epitopes used to generate the antiShot antisera NB (Gregory and Brown, 1998) , C-term (Strumpf and Volk, 1998) and 204 (this work). Areas deleted in the 5 deletion constructs are indicated by ''X'' and annotated. Note that DCalp1 carries an alternative Nterminus (hatched) belonging to isoform C (see Fig. 6 ). tin, is essential for its function in tendon cells. DEF and Drod both achieved very good quantitative rescues. However, tendon cells rescued through Drod deviated qualitatively from other successful rescues in that their cytoskeletal arrays were unusually elongated in 75% of cases (Figs. 5 and S2) . None of the used constructs caused obvious dominant negative effects when targeted to tendon cells in wildtype embryos and larvae. Such experiments revealed normal localisation pattern along cytoskeletal arrays and at apical and basal hemiadherens junctions of DCalp1 and DEF (Fig. 5) . Only DGas2 and Drod showed a slight deviation in that they failed to enrich at apical hemiadherens junctions ( Fig. 5D and F) , and this observation may relate to their incomplete rescue capabilities.
In order to confirm the surprising tendon cell rescue with DCalp1, we made use of the hypomorphic mutant allele shot kakP2 . This allele carries an insertion of a transposable element into the intron between the second and third transcriptional start sites of shot (Fig. 6A) , believed to abolish all Shot isoforms containing the first Calponin domain (Gregory and Brown, 1998; Lee et al., 2000; Rö per and Brown, 2003 phenotypes (Fig. 6 ). In contrast, motorneuronal dendrites are strongly reduced, Fasciclin2 fails to compartmentalise properly at the somatodendritic border, and motoraxons stall in shot kakP2 mutant embryos (Fig. 6) . Thus, shot kakP2 mutant embryos reproduce the results obtained from DCalp1 rescue. We conclude that the first Calponin domain, believed to mediate most of Shot's actin binding activity (Lee and Kolodziej, 2002b) , is required in neurons but dispensable in tendon cells.
2.4.
The Plakin domain is required in neurons, but not tendon cells
Having established the requirement of Calponin1, Spectrin rod, EF-hand and Gas2 domains in three cellular contexts, we addressed functions of the Plakin domain of Shot which has so far never been analysed. To bridge this gap, we generated transgenic flies for the targeted expression of Shot-DPlakin::GFP (DPlakin; Fig. 3 ). When driving this construct in tendon cells, it localised normally and achieved a full rescue of the shot mutant stretch phenotype (Fig. 7) . In contrast, when driving DPlakin in neurons, it completely failed to rescue the shot mutant Fasciclin2 mislocalisation phenotype in the somatodendritic area of motorneurons (Fig. 7) . This dysfunction of DPlakin is intriguing, since the construct localises normally in the somatodendritic area where it even achieves a full rescue of the shot mutant dendritic growth phenotypes (Fig. 7) .
In contrast to dendrites, we observed a strong mislocalisation phenotype in developing motoraxons of aCC and RP2. Initially, DPlakin localises normally at their growth cones at early stages of their outgrowth, but stays behind during further elongation when it tends to localise strongly along the entire length of the proximal axonal segment (Fig. 7I-J  0 ) . Accordingly, we find that targeted expression of DPlakin in shot mutant motorneurons achieves only a partial 47% rescue of the motoraxonal stall phenotype (significantly different from Shot::GFP rescue or shot alone; p WM 6 0.002). This deviation between failed axonal and successful dendritic rescue of DPlakin could reflect either a qualitative difference between these neuronal compartments, or a general transport problem. Thus, dendrites of RP2 and aCC motorneurons are positioned extremely close to the cell body, whereas their axons are amongst the longest motoraxons in the embryo (Landgraf et al., 2003) . To test whether mere distance makes a difference, we carried out rescue experiments with MzVUM-Gal4-positive motorneurons (in which the dendrites are positioned further away from the somata; Landgraf et al., 2003) and in motoraxons of the ISNb nerve (which is amongst the shortest in the embryo; Prokop, 2006) . Even with these more equalised distances, DPlakin produced a partial rescue of axonal extension (67%, significantly different from wildtype and shot; p WM 6 0.002), but a full rescue of dendritic growth. We conclude that the Plakin domain is required for axon but not dendrite extension. Taken together, we have uncovered two sub-cellular contexts in motorneurons where the Plakin domain clearly contributes to the function of Shot. These data provide the first indication for a role of Plakin domains in long isoforms of Spectraplakins and represent the first in vivo data for Plakin domain function of any Spectraplakin.
Discussion
Here we carried out a structure-function analysis of Shot in three shot-dependent cellular or sub-cellular contexts in vivo. These contexts were chosen with the expectation that they reflect very different cytoskeletal dynamics and requirements: dynamic actin-microtubule interaction in neuronal growth, highly stable arrays of actin filaments and microtubules in tendon cells, and cortical F-actin networks in the somatodendritic area of motorneurons. These choices served their purpose and helped to reveal distinct domain requirements of Shot: the only domain with a requirement in all three contexts is the Gas2 domain, the Plakin domain is essential for the compartmentalised localisation of the cell adhesion molecule Fasciclin2 and for axonal growth, and the first Calponin domain proved essential in neuronal contexts but not in tendon cells (Table 1) . A number of important statements can be deduced and will be discussed in the following.
The context-specific requirement for Calponin domains correlates with endogenous isoform distribution
Spectraplakins are generally considered to be essential actin-microtubule linker molecules (Jefferson et al., 2004; Rö per et al., 2002) . Main mediators of this function are the C-terminal Gas2 domain (associating with microtubules) and the first Calponin domain (as the main mediator of F-actin interaction; Lee and Kolodziej, 2002b) . In agreement with this view, we find that both neuronal functions of Shot analysed here require the first Calponin and the Gas2 domains in parallel (Table 1) . However, in tendon cells the first Calponin domain was dispensable. This result is very surprising, given the high amount of F-actin expressed in this cellular context (Alves-Silva et al., 2008) . Similarly, previous structure-function analyses in developing trachea (another non-neuronal Shot-dependent context) demonstrated the first Calponin domain to be dispensable, although it was required in the absence of the Gas2 domain (Lee and Kolodziej, 2002a) . Thus, tendon cells and trachea represent two examples in which Shot's predominant function seems not to require its ability to crosslink F-actin and microtubules.
This observation helps to explain our current knowledge about Shot isoforms and their distribution. Thus, the presence of Calponin domains is isoform-specific and regulated through differential transcriptional start sites: two N-terminal Shot isoforms contain both Calponin domains (isoform A, B), isoform C contains only the second Calponin domain, and isoform D lacks both Calponin domains ( Fig. 6 ; Lee et al., 2000; Rö per and Brown, 2003) . Interestingly, there is a shift during embryonic development from isoforms A/B to C/D (Rö per and Brown, 2003) , and isoforms C/D are virtually absent from the nervous system but strongly expressed in other tissues, especially in epidermal tendon cells ( Fig. 6 ; Lee et al., 2000) . Our data suggest that the first Calponin domain is indeed dispensable in tendon cells, thus demonstrating an in vivo function for isoforms C and/or D.
In contrast to the Calponin domains, all Shot isoforms predicted in FlyBase (Drysdale et al., 2005) contain the Gas2 domain (although one potential C-terminally truncated isoform has been proposed by others; Lee et al., 2000) . In agreement with this notion, the Gas2 domain is essential in neurons as well as in tendon cells.
The potential role for Shot in tendon cells
In shot mutant tendon cells, apicobasal arrays of microtubules do not show the typical attachment to hemiadherens junction on the basal cell surface (Prokop et al., 1998) . Current models propose Shot to act as a linker between microtubule arrays and peripheral F-actin (Rö per et al., 2002) , which is highly enriched at hemiadherens junctions (Alves-Silva et al., 2008; Fig. 5A ). However, this hypothesis is now questionable given that the first Calponin domain is dispensable in this context. Alternatively, the Plakin domain could serve as an essential anchor to hemiadherens junctions, as is the case for the Plakin domain of the mammalian Spectraplakin BPAG1, which links to transmembrane components of hemidesmosomes (Aumailley et al., 2006; Hopkinson and Jones, 2000; Koster et al., 2003) . However, our data do not reveal any obvious requirement for the Plakin domain of Shot in tendon cells. As a further alternative, previous work implied isoform-specific Plakin repeats of Shot to mediate interaction with cell adhesion complexes in epithelial tissues (Rö per and Brown, 2003) . However, the rescue constructs used in our study lack these Plakin repeats.
If indeed all these N-terminal domains of Shot are of little functional importance in tendon cells, Shot is less likely to act as a cytoskeleton-to-cell surface linker in tendon cells, in contrast to BPAG1 at hemidesmosomes. What could be alternative roles for Shot in tendon cells? Shot could be involved in different cellular processes in tendon cells. First, during tendon cell development, microtubules originate on the apical side and their plus ends need to be targeted to the basal surface (Tucker et al., 2004) . Shot might play a role in this targeting event. In agreement with this notion, Shot has recently been demonstrated to interact and co-localise in tendon cells with the microtubule plus end-binding molecules EB1 and APC (Subramanian et al., 2003) , and these molecules are known to regulate cortical targeting processes of microtubules (Lansbergen and Akhmanova, 2006) . Second, microtubules are highly stable and arranged into prominent arrays in tendon cells (Alves-Silva et al., 2008) . Shot may be an important mediator of this organisation, since Spectraplakins (including Shot) have the capacity to stabilise and bundle microtubules (Lee and Kolodziej, 2002b; Sun et al., 2001) .
In addition, all models for Shot function in tendon cells will have to consider the Spectrin-repeat rod domain, in the absence of which Shot appears mislocalised and microtubule arrays are elongated. In this context, new reports are of interest showing a requirement of the Spectrin-repeat rod for the function also of the mammalian Shot orthologue ACF7 in the context of cell migration (Wu et al., 2008) .
A functional role for the Plakin domain of Shot
Plakin domains are common to all Spectraplakin proteins and all their isoforms. They mediate protein-protein interactions and are composed of a series of Spectrin repeats with an embedded putative SH3 domain (Jefferson et al., 2004; Lee et al., 2000; Rö per et al., 2002; Young and Kothary, 2007) . We found the Plakin domain to be absolutely essential for the compartmentalisation of Fasciclin2 in neurons, for the transport, targeting and/or function of Shot in growing motoraxons, but not for dendritic growth and tendon cell structure.
So far, few functions have been suggested for Plakin domains of other Spectraplakins, and none of these is supported by unequivocal in vivo data. First, fractions of some Plakin domains (termed M1 domain) can bind microtubules (Karakesisoglou et al., 2000; Yang et al., 1999) , but only in isolation (Sun et al., 2001 ). Second, a nuclear localisation sequence in the Plakin domain helps to target BPAG1 to the nucleus (Young et al., 2003) . In agreement, PSORT predicts a 78.3% likelihood of nuclear localisation of the Shot-PG isoform (with 4 of 8 predicted nuclear localisation signals mapping to the Plakin domain), and N-terminal Shot constructs containing the Plakin domain localise to the nucleus (Subramanian et al., 2003; own observations). However, we never saw nuclear localisation of full length Shot::GFP and consider such a function of the Plakin domain to be irrelevant in the contexts we have analysed so far. Third, in keratinocytes, the Plakin domain of BPAG1 binds to b4 integrin and transmembrane Collagen XVII (BPAG2/BP180), thus targeting it to hemidesmosomes (Aumailley et al., 2006; Hopkinson and Jones, 2000; Koster et al., 2003) . This principal ability of Plakin domains to interact with membrane-associated proteins is currently the best explanation for the role of the Shot Plakin domain in Fasciclin2 localisation. Based on available data we propose a model in which the gigantic Shot molecule acts as a direct linker between the microtubule core and the F-actin-rich cortex of neurites in order to orchestrate cortical domains. In the context of such a linker function, the Plakin domain could promote molecular interactions with transmembrane or juxtamembrane proteins which, in turn, could impact on the localisation of Fasciclin2. However, we do not believe that Fasciclin2 interacts directly with Shot (Fasciclin2 is known to be targeted through PDZ domain proteins; 
Comparable principal mechanisms of dendritic and axonal growth
Axons and dendrites display a very different morphology. Although the growth of both structures essentially depends on actin and microtubule dynamics, there are still not enough insights into mechanisms of dendrite growth to compare the mechanisms underlying their development. We propose that principal mechanisms of dendrite extension are comparable to axonal growth and that Shot plays similar principal roles in both neurite types. First, we find that Shot is not required for dendrite initiation but their elongation (Fig. 1) , and the same can be said for Shot function in axons (Lee and Kolodziej, 2002b) . Second, Shot enriches in developing dendrites as well as in axonal growth cones (Fig. 1) , i.e. it adopts a strategic position at the site of growth in both neurite types. Third, our structure-function analyses reveal that Shot acts as an actin-microbubule linker in dendrites and also depends on its EF-hand motifs, as is the case for axons (Lee and Kolodziej, 2002b) .
A further argument in favour of common principal growth mechanisms of dendrites and axons can be deduced from manipulations of Rho GTPases, i.e. factors known to regulate cytoskeletal dynamics in neuronal growth (Govek et al., 2005) . Dendrites and axons are both mildly reduced in size if constitutively active Cdc42
V12 is expressed (Kim et al., 2003; Sá nchez-Soriano et al., 2005) , severely shortened (but not absent) upon Rac1 V12 expression (unpublished data), and embryos lacking any Rac function show no obvious reduction in overall dendritic or axonal growth (unpublished data). Interestingly, Shot::GFP concentration in both dendrites and axonal growth cones is abolished upon Rac V12 expression (data not shown). Hence, GTPase-manipulations cause the same effects in both neurite types, supporting the idea of shared principal growth mechanisms. However, an obvious mechanistic difference is the partial requirement for the DPlakin domain in axonal but not dendritic growth. Such defects might not reflect a distinction in cytoskeletal regulation through Shot, but reflect a secondary effect due to aberrant transport or targeting of Shot (Fig. 7) . That such targeting mechanisms are distinct between axons and dendrites is a well established fact (Hirokawa and Takemura, 2005) .
4.
Materials and methods
Fly strains
Used mutant fly stocks: shot 3 (courtesy of Kolodziej; Lee et al., 2000) , shot sf20 (Prokop et al., 1998) , shot kakP2 (P{lacW}-
; DGRC Kyoto, Japan; Gregory and Brown, 1998; Lee et al., 2000) (a gift from Lee et al., 2007) . Gal4 driver lines used: eve-Gal4 RN2D+O (2nd chromosome) and eve-Gal4 RN2E (3rd chromosome; both courtesy of Janes and Fujioka et al., 1999) , MzVUM-Gal4 (courtesy of Urban; Landgraf et al., 2003) , elav-Gal4 (Bloomington Stock Centre; Luo et al., 1994) , sr-Gal4 (courtesy of Volk; Alves-Silva et al., 2008; Subramanian et al., 2003) . Used transgenic UAS lines: UAS-shot-LA::GFP and its derivatives DCalp1, Drod, DEF, DGas2 (Fig. 3, Plasmid rescue of shot kakP2 was based on HinP1I, HpaII and Sau3AI digestion following standard protocols from BDGP (http://www.fruitfly.org/about/methods/inverse.pcr.html). Our results indicated a P-element insertion at the genomic position 9, 807, 300 (accession number FJ869115; Fig. 6 A) , which is in agreement with the previously reported insertion at 1917 bp before the first exon common to mRNAs encoding Shot isoforms A and B (Lee et al., 2000) . Fig. 3 ), or the shot kakP2 mutant allele over Df(2)MK1; ''tendon cells'', rescue of tendon cells (Fig. 5) , ''Fas2 loc.'', rescue of Fasciclin2 localisation in nerve roots (Fig. 4) ; ''dendr. growth'', rescue of dendritic growth; ''moto/senso'', rescue of axonal growth of moto-or sensory neurons; ''tracheal fusion'', rescue of tracheal phenotypes. ''+'' indicates full, ''±'' partial, and ''À'' no rescue; ''n.d.'', not determined. Lee andmu Kolodziej, 2002a . b Lee and Kolodziej, 2002a. c Our data.
4.3.
Generating transgenic flies for the expression of DPlakin
The DPlakin construct engineered here is a derivative of p{UAST}-Shot-L(A)-GFP (Lee and Kolodziej, 2002b) and lacks amino acids 488-1325 (Fig. 3) . Detailed cloning steps for DPlakin are described elsewhere (Bottenberg, 2004) . Injection of these constructs for the generation of transgenic flies was carried out at BestGene Inc. (Rustic Bridge, Chino Hills, CA 91709).
4.4.
Generation of anti-Shot 204 antibodies
Oligopeptides representing 14 amino acid stretches of the second Calponin domain of Shot were predicted to be antigenic by Vector NTI 7 software and chemically synthesised for the immunisation of rabbits (antigen code EP011204: H2N-LDPEDVDTNEPDEKSC-CONH2; immunisation program DE01369 at Eurogentec Bel S.A., Herstal, Belgium). Partial volume of the serum was used for small scale affinity purification against the epitope. To test specificity of the antiserum, protein was extracted in regular Laemmli buffer (Laemmli, 1970 ) from larvae expressing GFP-tagged N-terminal domains of Shot (Subramanian et al., 2003) through mechanical distruction and subsequent incubation at 100°C for 15 min. Protein was run on a SDS-Page gel, blotted on a polyvinylidene fluoride (PVDF) microporous membrane and stained with anti-Shot 204 (1:100) following standard procedures (data not shown).
4.5.
RNA analysis of shot kakP2 5 0 RACE (rapid amplification of 5 0 cDNA ends) was used to analyse, the shot isoforms expressed in shot kakP2 mutant embryos. Their RNA was isolated using the Nucleospin RNAII Kit (Macherey-Nagel) following the manufacturer's protocol. RNA was transcribed into cDNAvia the SuperscriptIII RT (Invitrogen) according to manufacturer's protocols and using primer SP1 (GTGTTCATGCGATACCAGG) which recognises all shot isoforms (Fig. 6B ) and points towards the Shot N-terminus. Homopolymeric A-tails were added to 3 0 ends of the first strand cDNAs using a terminal transferase (5 0 /3 0 RACE Kit 2nd generation, Roche Applied Sciences) and dATP. Subsequently, 5 0 cDNA ends were amplified via PCR using an oligo-dT (5 0 /3 0 RACE Kit) and the nested (slightly 5 0 to SP1) shot specific primer SP2 (TTCTC ATCCGGCTCGTTGG). Two bands were amplified, cloned into pCRII (TOPO) and sequenced (Fig. S4) . To amplify all existing 5 0 regions of shot isoforms, RNA was isolated from wildtype and shot kakP2 mutant embryos and transcribed into cDNA (see above), then amplified using the non-discriminate primer SP1 (see above) in combination with isoform-specific primers RA (GGCGTTTATCTGCTAGAACT), RB (GGGAAATCGGAAGGTTCA) and RC (ACATTTCACGATACCTCTCC), as illustrated in Fig. 6 .
Dissection and injection of embryos
Flat dissections of embryos at all stages were carried out following procedures detailed elsewhere (Budnik et al., 2006) . To analyse the potential rescue capability of Shot deletion constructs in tendon cells, pulled out glass capillaries (GB 100TF-8P; Science Products, Hofheim, Germany) were used to inject 0.1 M PBS containing Phalloidin-TRITC (1:200), formaldehyde (4%) and Triton X-100 (0.3%) into the anterior pole of late stage 17 embryos. To this end, dechorionated embryos were fixed to heptane glue-coated cover slips and covered with Voltalef oil, as detailed elsewhere (Prokop and Technau, 1993) . Embryos were pressure-injected until they stretched out to full length rupturing the vitelline membrane. Embryos were embedded in glycerol and immediately imaged.
Immunohistochemistry
Dissected embryos were fixed in 4% paraformaldehyde in 0.05 M phosphate buffer for 30-60 min, washed for 1 h in PBT, then stained with the following antibodies dissolved in PBT: anti-mCD8 (rat, 1:10, Caltag Laboratories), anti-Fasciclin2 (mouse, 1:10, Developmental Studies Hybridoma Bank; VanVactor et al., 1993) , anti-Fasciclin3 (clone 7G10, mouse, 1:10, Developmental Studies Hybridoma Bank; Patel et al., 1987) , TRITC-or Alexa647-coupled Phalloidin (1:100 or 1:500; Invitrogen, Molecular Probes), anti-Shot C-term (guinea pig, 1:100;
Strumpf and Volk, 1998), anti-Shot 204 (rabbit, 1:100), and various fluorescently tagged secondary antibodies (donkey, purified, 1:200; Jackson Laboratories).
Quantification of neurite growth
Motornerve length was scored relative to peripheral morphological landmarks. The SNb scored values from 0 to 4: 0 for not reaching the ventral longitudinal muscles (proximal/ ventral edge of VL4), 4 for reaching VL1, the most dorsal of the four ventral longitudinal muscles. The ISN scored 0-4 using a set of particular reference lines positioned with respect to the dorsal cluster of sensory neurons (Fig. S3 ). Data were analysed for each experimental day separately, pooled subsequently and normalised against wildtype or Shot::GFP rescued animals. Dendrite growth was judged subjectively relative to Fasciclin2 landmarks from groups of experimental specimens treated in parallel to controls. Statistics were carried out in Sigma Stat using t-test or, if data failed the normality test, Mann-Whitney rank sum test. All data representations are as mean ± SEM.
